Ann L. Lee's most recent trade in Prime Medicine Inc was a trade of 180,995 Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Prime Medicine Inc | Ann L. Lee | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2025 | 180,995 | 180,995 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Ann L. Lee | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2025 | 180,995 | 180,995 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Ann L. Lee | Chief Technical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Aug 2025 | 180,995 | 0 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Ann L. Lee | Chief Technical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Aug 2025 | 180,995 | 0 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Ann L. Lee | Chief Technical Officer | Purchase of securities on an exchange or from another person at price $ 1.13 per share. | 21 May 2025 | 100,000 | 100,000 | - | 1.1 | 113,000 | Common Stock |
| Prime Medicine Inc | Ann L. Lee | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 80,416 | 241,248 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Ann L. Lee | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 275,000 | 275,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Ann L. Lee | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 80,416 | 160,832 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Ann L. Lee | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 180,995 | 180,995 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Ann L. Lee | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 180,995 | 180,995 | - | - | Stock Option (right to buy) |